NO933481D0 - QUATERNARY BASIC AMIDS, PROCEDURES FOR PREPARING PRODUCTS AND PHARMACEUTICAL MIXTURES CONTAINING THEM - Google Patents

QUATERNARY BASIC AMIDS, PROCEDURES FOR PREPARING PRODUCTS AND PHARMACEUTICAL MIXTURES CONTAINING THEM

Info

Publication number
NO933481D0
NO933481D0 NO933481A NO933481A NO933481D0 NO 933481 D0 NO933481 D0 NO 933481D0 NO 933481 A NO933481 A NO 933481A NO 933481 A NO933481 A NO 933481A NO 933481 D0 NO933481 D0 NO 933481D0
Authority
NO
Norway
Prior art keywords
group
alkyl
amids
procedures
mixtures containing
Prior art date
Application number
NO933481A
Other languages
Norwegian (no)
Other versions
NO933481L (en
NO304888B1 (en
Inventor
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of NO933481D0 publication Critical patent/NO933481D0/en
Publication of NO933481L publication Critical patent/NO933481L/en
Publication of NO304888B1 publication Critical patent/NO304888B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)

Abstract

The invention relates to basic quaternary amides of formula <IMAGE> in which - Ar represents an optionally substituted mono-, di- or tricyclic heteroaromatic or aromatic group; - T represents a direct bond, a hydroxymethylene group, an alkoxymethylene group in which the alkoxy group is C1-C4 or a C1-C5 alkylene group; - Ar' represents a phenyl which is unsubstituted or substituted one or a number of times, a thienyl, a benzothienyl, a naphthyl or an indolyl; - R represents hydrogen, a C1-C4 alkyl, an omega -(C1-C4)alkoxy(C2-C4)alkyl or an omega -(C1-C4)alkanoyloxy(C2-C 4)alkyl, - Q represents hydrogen; - or else Q and R, together, form a 1,2-ethylene, 1,3-propylene or 1,4-butylene group; - Am<(+)> represents the radical <IMAGE> in which X1, X2 and X3, together and with the nitrogen atom to which they are bonded, form an azabicyclic or azatricyclic system optionally substituted by a phenyl group; - A<(-)> is a pharmaceutically acceptable anion. These compounds are useful in the preparation of medicaments intended for the treatment of pathologies involving the tachykinin system.
NO933481A 1992-09-30 1993-09-29 Quaternary basic amides and pharmaceutical mixtures containing them NO304888B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9212083A FR2696178B1 (en) 1992-09-30 1992-09-30 Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.

Publications (3)

Publication Number Publication Date
NO933481D0 true NO933481D0 (en) 1993-09-29
NO933481L NO933481L (en) 1994-04-05
NO304888B1 NO304888B1 (en) 1999-03-01

Family

ID=9434374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933481A NO304888B1 (en) 1992-09-30 1993-09-29 Quaternary basic amides and pharmaceutical mixtures containing them

Country Status (27)

Country Link
EP (1) EP0591040B1 (en)
JP (2) JP2857041B2 (en)
KR (1) KR100279084B1 (en)
CN (1) CN1036652C (en)
AT (1) ATE176469T1 (en)
AU (1) AU674875B2 (en)
BR (1) BR9303982A (en)
CA (1) CA2107432C (en)
CZ (1) CZ287272B6 (en)
DE (1) DE69323375T2 (en)
DK (1) DK0591040T3 (en)
ES (1) ES2130238T3 (en)
FI (1) FI114474B (en)
FR (1) FR2696178B1 (en)
GR (1) GR3030000T3 (en)
HU (2) HU215848B (en)
IL (1) IL107158A0 (en)
MX (1) MX9306024A (en)
MY (1) MY108881A (en)
NO (1) NO304888B1 (en)
NZ (1) NZ248821A (en)
OA (1) OA09869A (en)
RU (1) RU2120436C1 (en)
SG (1) SG47807A1 (en)
SI (1) SI9300513B (en)
TW (1) TW242625B (en)
ZA (1) ZA937276B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
FR2717802B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
FR2717804B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them.
IL113472A0 (en) 1994-04-29 1995-07-31 Lilly Co Eli Non-peptidyl tachykinin receptor antogonists
RU2151769C1 (en) 1994-07-12 2000-06-27 Эли Лилли Энд Компани (r)-3-(1h-indole-3-yl)-1-[n-(2-methoxybenzyl)acetylamino]-2- -[n-(2-(4-piperidine-1-yl)piperidine-1-yl)acetyl)amino]propane dihydrochloride trihydrate and pharmaceutical composition
FR2725900B1 (en) * 1994-10-21 1997-07-18 Sanofi Sa USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
CA2162786A1 (en) * 1994-11-22 1996-05-23 Philip Arthur Hipskind Heterocyclic tachykinin receptor antagonists
FR2751654B1 (en) * 1996-07-26 1998-10-23 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729951B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2729952B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729954B1 (en) * 1995-01-30 1997-08-01 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69626123T2 (en) * 1995-06-06 2003-10-09 Schering Corp., Kenilworth SUBSTITUTED BENZO-CONDENSED HETEROCYCLES AS NEUROKININ ANTAGONISTS
US5654316A (en) * 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
FR2745811B1 (en) * 1996-03-07 1998-05-22 Sanofi Sa DISSUBSTITUTED GLUTARIMIDE PROCESS FOR ITS PREPARATION, AND ITS USE
WO1997044035A1 (en) * 1996-05-24 1997-11-27 Eli Lilly And Company Methods of treating hypertension
US5691362A (en) * 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
GB9617730D0 (en) * 1996-08-23 1996-10-02 Pfizer Ltd Quarternary ammonium compounds
FR2759585B1 (en) 1997-02-17 1999-06-11 Sanofi Sa PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
FR2759584B1 (en) * 1997-02-17 1999-06-11 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM
AU744261B2 (en) * 1997-04-24 2002-02-21 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating eating disorders
GB9712882D0 (en) * 1997-06-18 1997-08-20 Pfizer Ltd Quaternary ammonium compounds
AU738047B2 (en) * 1997-08-04 2001-09-06 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating mania
GB9716463D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
AU737019B2 (en) * 1997-08-04 2001-08-09 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating aggressive behaviour disorders
GB9716457D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
GB9927125D0 (en) 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
WO2005080339A1 (en) * 2004-02-25 2005-09-01 Sankyo Company, Limited Sulfonyloxy derivatives
CN104922117A (en) 2005-03-22 2015-09-23 阿泽范药品公司 Beta-lactamylalkanoic acids for treating premenstrual disorders
DK1910346T3 (en) 2005-07-19 2019-05-27 Azevan Pharmaceuticals Inc BETA-LACTAMYL FENYLALANINE, CYSTEIN AND SERIN VASOPRESSIN ANTAGONIST
BRPI0807972A2 (en) 2007-01-24 2014-06-10 Glaxo Group Ltd PHARMACEUTICAL COMPOSITIONS UNDERSTANDING 3,5-DIAMINO-6- (2,3-DICHLOPHENYL) -L, 2,4-TRIAZINE OR R (-) - 2,4-DIAMINO-5- (2,3-DICHLOROPHENYL) -6- FLUOROMETILPIRIM IDINA AND ONE NK1
UA105182C2 (en) 2008-07-03 2014-04-25 Ньюрексон, Інк. Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
PL2587919T3 (en) 2010-07-01 2018-05-30 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
MX2021005502A (en) 2014-03-28 2023-01-16 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases.
RU2722720C1 (en) * 2016-12-14 2020-06-03 Бейджинг Шоубай Фармасьютикэл Ко., Лтд. Class of bifunctional compounds with quaternary ammonium salt structure
AU2018333051B2 (en) 2017-09-15 2024-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97540C (en) * 1989-11-06 1997-01-10 Sanofi Sa Process for the preparation of therapeutically useful aromatically substituted piperidine and piperazine derivatives
FR2666185B1 (en) * 1990-08-21 1992-12-04 Sgs Thomson Microelectronics INTERPOLATION ANALOG / DIGITAL CONVERTER.
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SI9300513A (en) 1994-06-30
MY108881A (en) 1996-11-30
SI9300513B (en) 2002-02-28
CN1036652C (en) 1997-12-10
NO933481L (en) 1994-04-05
MX9306024A (en) 1994-03-31
HU9302770D0 (en) 1993-12-28
HU211889A9 (en) 1995-12-28
FI934273A (en) 1994-03-31
NO304888B1 (en) 1999-03-01
KR940007026A (en) 1994-04-26
HU215848B (en) 1999-04-28
ATE176469T1 (en) 1999-02-15
TW242625B (en) 1995-03-11
KR100279084B1 (en) 2001-01-15
EP0591040A1 (en) 1994-04-06
NZ248821A (en) 1995-10-26
IL107158A0 (en) 1993-12-28
FR2696178B1 (en) 1994-12-30
DK0591040T3 (en) 1999-09-20
CN1088582A (en) 1994-06-29
AU4870893A (en) 1994-04-14
ZA937276B (en) 1994-04-25
EP0591040B1 (en) 1999-02-03
GR3030000T3 (en) 1999-07-30
HUT65759A (en) 1994-07-28
CZ203593A3 (en) 1994-04-13
FI114474B (en) 2004-10-29
FR2696178A1 (en) 1994-04-01
BR9303982A (en) 1994-10-25
CA2107432C (en) 2000-04-04
JPH10175976A (en) 1998-06-30
FI934273A0 (en) 1993-09-29
AU674875B2 (en) 1997-01-16
DE69323375D1 (en) 1999-03-18
RU2120436C1 (en) 1998-10-20
DE69323375T2 (en) 1999-06-24
JP3243212B2 (en) 2002-01-07
ES2130238T3 (en) 1999-07-01
CA2107432A1 (en) 1994-03-31
JP2857041B2 (en) 1999-02-10
OA09869A (en) 1994-08-15
CZ287272B6 (en) 2000-10-11
JPH06211850A (en) 1994-08-02
SG47807A1 (en) 1998-04-17

Similar Documents

Publication Publication Date Title
NO933481D0 (en) QUATERNARY BASIC AMIDS, PROCEDURES FOR PREPARING PRODUCTS AND PHARMACEUTICAL MIXTURES CONTAINING THEM
RU93055131A (en) QUARTERLY AMIDES OF BASIC CHARACTER, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITION
ES2085865T3 (en) DERMORPHINE ANALOGS, THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC TREATMENT METHODS THAT USE THEM.
IL99022A0 (en) Compositions containing cyclodextrin complexes for neuraxial administration of drugs
UA32525C2 (en) Gastric juice-resistant drug for oral administration containing pantoprazole
GB2193633B (en) Psycho-active pharmaceutical compositions containing indolyl derivatives
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
FR2613624B1 (en) ORAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION FOR REDUCING THE EFFECTS OF B-LACTAMINES
DK177890A (en) PHARMACEUTICAL PREPARATION CONTAINING N-ACETYL CYSTEIN FOR ORAL ADMINISTRATION
ATE111912T1 (en) XANTHIND DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
PT88682A (en) A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING PIPERIDINOALKANOL-DECONGESTANT COMBINATION
IL44794A0 (en) Pharmaceutical compositions containing certain triazolyl derivatives
DE3269309D1 (en) Pyrrolo(2,3-d)carbazole derivatives, preparation thereof and their therapeutical use
PT85542B (en) Process for preparing pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
IL87444A0 (en) Pharmaceutical compositions containing polyaromatic compounds
PT82634A (en) Process for preparing novel alkaloid compounds containing a berban skeleton useful as medicaments
IL86096A0 (en) Extended release pharmaceutical compositions containing cholinergic amines
SG135693G (en) Psycho-active pharmaceutical compositions containing indolyl derivatives
IL85265A0 (en) Pharmaceutical compositions containing polyaromatic compounds
GB8306240D0 (en) Pharmaceutical formulations containing azapropazone/indomethacin
HU895452D0 (en) Process for the preparation of pharmaceutical compositions of new dose form

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees